Cameron John Reynolds, President and CEO at VOLITIONRX LTD (VNRX), bought 1,100 shares at $4.24 ($5K) on 2019-12-05, disclosed to the SEC on 2019-12-06.
Open-market purchase of $5k VNRX by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| VNRX | BUY | 2025-09-15 | $10K | — | Filing → |
| VNRX | BUY | 2025-08-06 | $50K | — | Filing → |
| VNRX | BUY | 2025-06-16 | $7K | — | Filing → |